| http://www.w3.org/ns/prov#value | - The humanized antibodies of the present invention include complete antibody molecules having full length heavy and light chains, or any fragment thereof, such as the Fab or (Fab???)2 fragments, a heavy chain and light chain dimer, or any minimal fragment thereof such as an Fv, an SCA (single chain antibody), and the like that exhibits immunospecific binding for the Fc??RIIB.
|
